Хайлтын үр дүнгүүд - Akash Patnaik
- 24-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
Ubiquitin is part of the retrovirus budding machinery -н Akash Patnaik, Vincent Chau, John W. Wills
Хэвлэсэн 2000Artigo -
2
-
3
Targeting Innate Immunity in Cancer Therapy -н Srikrishnan Rameshbabu, Brian Labadie, Anna Argulian, Akash Patnaik
Хэвлэсэн 2021Revisão -
4
Mouse Models for Cancer Immunotherapy Research -н Brian M. Olson, Yadi Li, Yu Lin, Edison T. Liu, Akash Patnaik
Хэвлэсэн 2018Revisão -
5
-
6
-
7
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis -н Kiranj Chaudagar, Hanna M. Hieromnimon, Anne Kelley, Brian Labadie, Jordan Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela Bynoe, Ani Solanki, Erica Markiewicz, Xiaobing Fan, Massimo Loda, Akash Patnaik
Хэвлэсэн 2023Artigo -
8
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial -н Padmanee Sharma, Russell K. Pachynski, Vivek Narayan, Aude Fléchon, Gwénaëlle Gravis, Matthew D. Galsky, Hakim Mahammedi, Akash Patnaik, Sumit K. Subudhi, Marika Ciprotti, Burçin Şimşek, Abdel Saci, Yanhua Hu, G. Celine Han, Karim Fizazi
Хэвлэсэн 2020Artigo -
9
Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated an... -н Wassim Abida, David Campbell, Akash Patnaik, Brieuc Sautois, Jeremy Shapiro, Nicholas J. Vogelzang, Alan H. Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jie Zhang, Andrew D. Simmons, Darrin Despain, Matthew Dowson, Tony Golsorkhi, S. Chowdhury
Хэвлэсэн 2019Artigo -
10
ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer -н Shuai Gao, Huihui Ye, Sean Gerrin, Hongyun Wang, Ankur Sharma, Sen Chen, Akash Patnaik, Adam G. Sowalsky, Olga Voznesensky, Wanting Han, Ziyang Yu, Elahe A. Mostaghel, Peter S. Nelson, Mary-Ellen Taplin, Steven P. Balk, Changmeng Cai
Хэвлэсэн 2016Artigo -
11
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer -н Elena Garralda, Ammar Sukari, Nehal J. Lakhani, Akash Patnaik, Yiyun Lou, Seock‐Ah Im, Talia Golan, Ravit Geva, Martin Wermke, Maria J. de Miguel, J. Palcza, S. Jha, Marya Chaney, Anson K. Abraham, Jasmine Healy, Gerald S. Falchook
Хэвлэсэн 2022Artigo -
12
Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombinat... -н Wassim Abida, Alan H. Bryce, Nicholas J. Vogelzang, R. J. Amato, Ivor Percent, Julia Shapiro, Ray McDermott, Arif Hussain, Akash Patnaik, Daniel P. Petrylak, Charles J. Ryan, T. Stanton, Jie Zhang, Andrew D. Simmons, Darrin Despain, Marnie Collins, T. Golsorskhi, Howard I. Scher, S. Chowdhury
Хэвлэсэн 2018Artigo -
13
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY) -н Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Fréderic Pouliot, Stephan Probst, Lawrence Saperstein, Mark A. Preston, Ajjai Alva, Akash Patnaik, Jeremy C. Durack, Nancy Stambler, Tess Lin, Jessica Jensen, Vivien Wong, Barry A. Siegel, Michael J. Morris
Хэвлэсэн 2021Artigo -
14
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib -н Andrea Loehr, Arif Hussain, Akash Patnaik, Alan H. Bryce, Daniel Castellano, Albert Font, Jeremy Shapiro, Jingsong Zhang, Brieuc Sautois, Nicholas J. Vogelzang, Gurkamal Chatta, Kevin D. Courtney, Andrea Harzstark, Francesco Ricci, Darrin Despain, Simon P. Watkins, Charmin King, Minh Nguyen, Andrew D. Simmons, Simon Chowdhury, Wassim Abida
Хэвлэсэн 2022Artigo -
15
Vulnerabilities of <i>PTEN</i>–<i>TP53</i>-Deficient Prostate Cancers to Compound PARP–PI3K Inhibition -н Enrique González‐Billalabeitia, Nina Seitzer, Su Jung Song, Min Sup Song, Akash Patnaik, Xuesong Liu, Mirjam T. Epping, Antonella Papa, Robin M. Hobbs, Ming Chen, Andrea Lunardi, Christopher Ng, Kaitlyn A. Webster, Sabina Signoretti, Massimo Loda, John M. Asara, Caterina Nardella, John G. Clohessy, Lewis C. Cantley, Pier Paolo Pandolfi
Хэвлэсэн 2014Artigo -
16
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer -н Andrea Lunardi, Ugo Ala, Mirjam T. Epping, Leonardo Salmena, John G. Clohessy, Kaitlyn A. Webster, Guocan Wang, Roberta Mazzucchelli, Maristella Bianconi, Edward C. Stack, Rosina T. Lis, Akash Patnaik, Lewis C. Cantley, Glenn J. Bubley, Carlos Cordón-Cardo, William L. Gerald, Rodolfo Montironi, Sabina Signoretti, Massimo Loda, Caterina Nardella, Pier Paolo Pandolfi
Хэвлэсэн 2013Artigo -
17
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism -н Sarah‐Maria Fendt, Eric L. Bell, Mark A. Keibler, Shawn M. Davidson, Grégory J. Wirth, Brian P. Fiske, Jared R. Mayers, Matthias Schwab, Gary Bellinger, Alfredo Csibi, Akash Patnaik, Marie Jose Blouin, Lewis C. Cantley, Leonard Guarente, John Blenis, Michaël Pollak, Aria F. Olumi, Matthew G. Vander Heiden, Gregory Stephanopoulos
Хэвлэсэн 2013Artigo -
18
Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer -н Kiranj Chaudagar, Hanna M. Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al‐Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela Bynoe, Catherine Drovetsky, Ani Solanki, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan C. Schürer, Alexander Swarbrick, David B. Sykes, Akash Patnaik
Хэвлэсэн 2023Artigo -
19
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consort... -н Channing J. Paller, Emmanuel S. Antonarakis, Tomasz M. Beer, Hala T. Borno, Maria I. Carlo, Daniel J. George, Julie N. Graff, Shilpa Gupta, Elisabeth I. Heath, Celestia S. Higano, Rana R. McKay, Alicia K. Morgans, Akash Patnaik, Daniel P. Petrylak, Matthew B. Rettig, Charles J. Ryan, Mary‐Ellen Taplin, Young E. Whang, Jacob Vinson, Heather H. Cheng, Veda N. Giri
Хэвлэсэн 2019Artigo -
20
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Stud... -н Wassim Abida, David Campbell, Akash Patnaik, Jeremy Shapiro, Brieuc Sautois, Nicholas J. Vogelzang, Éric Voog, Alan H. Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jingsong Zhang, Josep M. Piulats, Karim Fizazi, Axel S. Merseburger, Celestia S. Higano, Laurence E. Krieger, Charles J. Ryan, Felix Y. Feng, Andrew D. Simmons, Andrea Loehr, Darrin Despain, Melanie Dowson, Foad Green, Simon P. Watkins, Tony Golsorkhi, Simon Chowdhury
Хэвлэсэн 2020Carta
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Cancer
Internal medicine
Prostate cancer
Biology
Cancer research
Oncology
Genetics
Gene
Immunotherapy
Prostate
Clinical trial
Androgen deprivation therapy
Biochemistry
Germline mutation
Mutation
PI3K/AKT/mTOR pathway
PTEN
Signal transduction
Androgen receptor
Bioinformatics
Cell biology
Chemistry
Computer science
DNA
DNA repair
Germline
Immune system
Immunology
PARP inhibitor